Menu
Recruiting NCT05940857

US National OCS Liver Perfusion (OLP) Registry

Observational Liver Transplant

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: OCS Liver.
Who it may be relevant to
Registry conditions: Liver Transplant. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight. TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.

Interventions

  • Device OCS Liver
    The TransMedics® Organ Care System (OCS) Liver is an FDA approved portable extracorporeal liver perfusion and monitoring system.

Primary outcome measures

  • Survival [Time frame: 5 years post-transplant]

Eligibility criteria

All liver transplant recipients.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

United States · 22 centers
  • University of Alabama — Birmingham
  • Mayo Clinic Hospital Arizona — Phoenix
  • University of California San Diego — La Jolla
  • University of California San Francisco — San Francisco
  • Mayo Clinic Hospital Florida — Jacksonville
  • Emory University Hospital — Atlanta
  • University of Kentucky Medical Center — Lexington
  • Beth Israel Deaconess Medical Center — Boston
  • … and 14 more centers

Identifiers

NCT: NCT05940857 · OCS-LIVER-OLP-II

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗